NAFLD clinical trial activity catching up in China but lacks substantial domestic participation, says GlobalData
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
The objective of this study is to evaluate the efficacy of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients.
Subscribe To Our Newsletter & Stay Updated